XBiotech Inc (XBIT)
XBiotech Inc (XBIT) is a biotechnology company focused on developing and commercializing investigational human therapeutic antibodies for the treatment of various diseases. It is known for its research on immune-based therapies, particularly its proprietary True Human™ monoclonal antibodies. The company's approach emphasizes safety and efficacy through the use of genetically engineered antibodies derived from human sources.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 23, 2021 | $2.10 | 2021-07-15 | 2021-07-16 |
Dividends Summary
- XBiotech Inc has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 1554 days ago, on July 23, 2021
- The highest dividend payed out to investors during this period was $2.10 per share
- The average dividend paid during this period was $2.10 per share.
Company News
Wolf Haldenstein Adler Freeman & Herz LLP is investigating XBiotech for potential securities law violations after the company announced issues with its Phase II rheumatoid arthritis drug study, leading to a 29% stock price drop.
Quince Therapeutics and XBiotech are included in this Analyst Blog.
Gainers Smart for Life, Inc. (NASDAQ: SMFL) shares climbed 86.2% to $4.32. Smart for Life announced Wednesday that it had executed a strategic agreement with CloudKitchens for rapid local delivery of its new line of innovative, proprietary, and healthy high-protein ice cream bars. Motus GI Holdings, Inc. (NASDAQ: MOTS) gained 63.6% to $1.1781 a...